Free intra-abdominal gas associated with octreotide use: intestinal perforation or benign pneumoperitoneum associated with underlying systemic sclerosis?
Joseph C
JC
Yarze
Michael P
MP
Chase
D000005:Abdomen; D005740:Gases; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D007416:Intestinal Perforation / Q000209:etiology*; D015282:Octreotide / Q000009:adverse effects*; D011027:Pneumoperitoneum / Q000209:etiology*; D012595:Scleroderma, Systemic / Q000150:complications*
D005740:Gases; D005765:Gastrointestinal Agents; D015282:Octreotide